某三甲医院临床路径管理的应用效果评价  

The Application Result Evaluation of the Clinical Pathway in One Third-class Hospital

作　　者：高士洪[1] 孙宏[1] 许凤娟[2] 藤双艳[2] 周铁英[2] 

机构地区：[1]哈尔滨医科大学,黑龙江哈尔滨150080 [2]哈尔滨医科大学附属第一医院,黑龙江哈尔滨150001

出　　处：《中国医院管理》2010年第9期14-16,共3页Chinese Hospital Management

基　　金：黑龙江省卫生厅课题资助(2007-239)

摘　　要：目的评价临床路径应用于7个有代表性单病种的临床效果。方法用历史对照法选取单病种6 865例实施临床路径管理(路径组)和6 902例非临床路径管理(非路径组),对住院费用、住院时间、抗生素的使用费用等指标进行综合比较、评价。结果路径组与非路径组住院费用、住院时间和抗生素费用比较,P均﹤0.05,2组在3项评价指标上比较,差异有统计学意义(P﹤0.05)。结论 7个单病种的临床路径管理可以降低住院费用及抗生素费用,缩短住院时间。Objective Evaluation clincal pathway of the clinical resullts has been applied to seven representative monodiseases. Methods Through selecting the monopathy management of 6 934 patients treated with the clinical pathway （the pathway group） and 6 896 patients receiving the routine treatment （the non-pathway group） by using history refer- ence method, the indexes including the cost of hospitalization, the hospitalization time and the antibiotic expense etc have been compared and evaluated comprehensively. Results There is a statistics meaning of the difference（P〈0.05）of two grouns which are the hospitalization cost of pathway group and non-pathway group, and in the comparision between hospitalization time and antibiotic cost, with both P〈0.05. Conclusions It is a feasible method that the clinical pathway is used in 7 monopathies to degrade the hospitalization cost and the antibiotics expense disease, and shorten the hospitalization time.

关 键 词：临床路径 单病种 住院费用 住院时间 临床效果 

分 类 号：R197.3[医药卫生—卫生事业管理]